Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Dry Eye Disease (2 trials), Dry Eye
- Main trialPhase 2
- “Double-masked two period controlled trial of three eyelid wipe dosing techniques”In the company’s words, NCT07140380 on ClinicalTrials.gov
Other drugs for Dry Eye Disease
- LicaminlimabOculis · Phase 2/3
- NipocalimabJohnson & Johnson (Janssen) · Phase 3
- VVN001VivaVision Biotech, Inc · Phase 3
- CAM-101Cambium Bio Limited · Phase 3
- TelitaciceptVor Biopharma · Phase 3
- OT202Ocumension Therapeutics (Shanghai) Co., Ltd · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | 8 Oct 2025 | Phase 2b Controlled Study | |
| Phase 2Completed | 3 Nov 2025 | Phase 2b Controlled Study of Dosing Techniques - Part B | |
| Phase 1/2Completed | 15 Oct 2024 | IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026